A Phase 1, Open-label, Randomized, 2-period Crossover Drug Interaction Study in Healthy Adult Subjects to Evaluate the Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of SSP-002358.
Phase of Trial: Phase I
Latest Information Update: 26 Jun 2014
At a glance
- Drugs SPD 557 (Primary) ; Omeprazole
- Indications Gastro-oesophageal reflux
- Focus Pharmacokinetics
- Sponsors Shire
- 29 Sep 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 29 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.